Cipher Pharmaceuticals (TSX:CPH) Days Sales Outstanding : 104.79 (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Cipher Pharmaceuticals Days Sales Outstanding?

Cipher Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was C$9.12 Mil. Cipher Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was C$7.94 Mil. Hence, Cipher Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 104.79.

The historical rank and industry rank for Cipher Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

TSX:CPH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 103.28 Med: 156.98 Max: 251
Current: 104.31

During the past 13 years, Cipher Pharmaceuticals's highest Days Sales Outstanding was 251.00. The lowest was 103.28. And the median was 156.98.

TSX:CPH's Days Sales Outstanding is ranked worse than
75.78% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.15 vs TSX:CPH: 104.31

Cipher Pharmaceuticals's Days Sales Outstanding declined from Mar. 2023 (114.29) to Mar. 2024 (104.79).

Cipher Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Cipher Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Days Sales Outstanding Chart

Cipher Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

158.99

154.97

132.11

115.42

103.28

Cipher Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															114.29	99.00	93.38	109.85	104.79

Competitive Comparison of Cipher Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cipher Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Days Sales Outstanding falls into.

Cipher Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cipher Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (9.241	+	6.826)	/	2 )	/	28.391	*	365
=	8.0335					/	28.391	*	365
=	103.28

Cipher Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (6.826	+	11.415)	/	2 )	/	7.942	*	365 / 4
=	9.1205					/	7.942	*	365 / 4
=	104.79

Cipher Pharmaceuticals (TSX:CPH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cipher Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cipher Pharmaceuticals (TSX:CPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (TSX:CPH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CPHRF:USA PHE:Germany

Address

5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9

Website

https://www.cipherpharma.com

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (TSX:CPH) Headlines

No Headlines